Chemicals and Drugs

Adenomatous Polyposis Coli Protein

A negative regulator of beta-catenin signaling which is mutant in ADENOMATOUS POLYPOSIS COLI and GARDNER SYNDROME.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

A negative regulator of beta-catenin signaling which is mutant in ADENOMATOUS POLYPOSIS COLI and GARDNER SYNDROME.

MeSH Record

Classification

Broader headings

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

MeSH Record

See Also

MeSH Record

Aspects Covered

30 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, agonists, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, deficiency, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, ultrastructure, urine.

MeSH Record

History Note

2002; use ADENOMATOUS POLYPOSIS COLI PROTEIN (NM) 1993-2001

MeSH Record

Previous Indexing

  • Cytoskeletal Proteins (1994-2001)
  • Neoplasm Proteins (1993-1994)

MeSH Hierarchy

Tree Numbers

  1. D05.500w.117.249
  2. D12.776w.220.040
  3. D12.776w.476.081.249
  4. D12.776w.624.776.010

AMA Style

References

  1. National Library of Medicine. Adenomatous Polyposis Coli Protein. Medical Subject Headings (MeSH). 2026. Unique ID D025601. http://id.nlm.nih.gov/mesh/2026/D025601
  2. Adenomatous Polyposis Coli Protein. In: Wikidata. https://www.wikidata.org/wiki/Q24771845